Skip to main content
. 2022 Jan 11;232:109291. doi: 10.1016/j.drugalcdep.2022.109291

Fig. 2.

Fig. 2

Trends in the Distribution of Medications for Opioid Use Disorder (MOUD) by Specific Medication in U.S. Prisons - January 2018 to October 2020. NSP = National Sales Perspectives; MOUD = medications for opioid use disorder. Data spans from January 2018 to October 2020. Monthly supply trends of MOUDs at U.S. prisons and jails from January 2018 to October 2020. Supply volume is reported in extended units, measured by the number of tablets or capsules for oral products and volume in milliliters for liquid products. The primary (left) y axis represents the number of extended units, in thousands, for specific MOUDs, while the total number of extended units for all MOUDs are charted on the secondary y-axis (right-axis). Using simple linear regression, buprenorphine, naltrexone, and overall MOUDs increased significantly annually from 2018 to 2020.